Keyphrases
Rhesus Macaque
100%
Nonhuman Primate
88%
Mycobacterium Tuberculosis (M. tb)
86%
Vaccination
77%
Aerosol
61%
Macaque
51%
Cynomolgus Macaque
49%
BCG Vaccine
48%
COVID-19
41%
Tuberculosis Vaccine
35%
Mycobacterium Tuberculosis Infection
35%
Vaccine Candidate
33%
Tuberculosis
32%
Lung
31%
MTBVAC
24%
Immunogenicity
23%
T Cells
23%
Mycobacterium
21%
Disease Burden
21%
Ultra-low Dose
20%
Protective Efficacy
19%
Challenge Model
19%
Aerosol Challenge
19%
Unvaccinated
19%
CD8+ T Cells
18%
Immune Response
16%
Mycobacterial Growth Inhibition Assay
16%
Ferret
16%
TB Vaccine
16%
Bacillus Calmette-Guérin
16%
Mycobacterium Bovis BCG
16%
Infection Model
16%
BCG Revaccination
16%
Antigen-specific
16%
Interferon-γ
15%
Immune Parameters
14%
T Cell Response
13%
Macaque Model
13%
T Cell Subpopulations
13%
Immune System
13%
Vaccine Evaluation
12%
Intradermal Route
11%
CD4 T Cells
11%
SARS-CoV-2 Challenge
10%
Antibody Titer
10%
High Dose
10%
Vaccine Strategy
9%
Antibody Titre
9%
IFN Response
9%
Vaccine Development
9%
Immunology and Microbiology
Rhesus Monkey
84%
Mycobacterium Bovis BCG
80%
Mycobacterium Tuberculosis
65%
Macaca
54%
Macaca fascicularis
42%
T Cell
42%
BCG Vaccine
37%
Cell Population
28%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Low Drug Dose
26%
Cytotoxic T-Cell
25%
Mycobacteria
25%
Antibody Titer
24%
Immunogenicity
23%
Immune Response
21%
CD4
20%
T-Helper Cell
17%
Growth Inhibition
16%
Peptides
14%
Memory T Cell
14%
Immune System
12%
Cytokine
12%
Immunocompetent Cell
12%
Tumor Necrosis Factor
11%
COVID-19
11%
Interferon Gamma
11%
Epitope
10%
Antigen Specificity
10%
Infectious Agent
10%
Drug Megadose
9%
Guinea Pig
9%
Antibody Response
9%
Peripheral Blood Mononuclear Cell
8%
Lymph Node
8%
Immunostimulation
8%
Ebola Virus
8%
Mustela Putorius Furo
8%
Mycobacterium antigen
8%
Inactivated Vaccine
8%
Coinfection
8%
Glycoprotein
8%
Antibody Blood Level
8%
Population Dynamics
8%
Titer
7%
Colony-Forming Unit
7%
B Cell
6%
Bronchoalveolar Lavage Fluid
6%
Bacterial Load
5%
Preclinical Study
5%
Coculture
5%
